Ionclinics, selected to receive an AVI

We start the development of a new device.

Ionclinics has been selected as one of the companies that will receive an AVI from the Valencian Agency of Innovation, funds that will be used to start the development of the new generation of brain neuromodulation device, for the treatment of the symptoms of pathologies in fields such as neurology, psychiatry or pain treatment.

The AVI is an economic aid promoted by the Generalitat Valenciana, which is granted through the Valencian Agency for Innovation and aims to improve the structure of the Valencian production model, supporting SMEs in the development of Research, Development and Innovation projects.

Our company, dedicated to the development and manufacture of electromedical devices for healthcare professionals, is developing the SMART Bipolar System, a non-invasive brain neuromodulation device, which will be the new version of our current EPTE Bipolar System device. The project will consist of researching and developing a technological solution based on Artificial Intelligence to improve the treatment of chronic diseases through non-invasive brain neuromodulation, which will reduce pain and improve the quality of life of patients and the recovery process, significantly reducing drug consumption and healthcare costs.

Non-invasive brain neuromodulation is a medical technique that consists of the application of magnetic fields or low intensity galvanic current on a specific area of the brain, with the aim of modulating cortical activity and modifying the brain's plastic capacities. Modifying this brain plasticity allows us to change the functionality and brain structure, favoring the treatment of the symptoms of different pathologies with great benefits that improve the patient's quality of life.

Currently in Spain, chronic diseases have a high prevalence. In 2020, spending on the care of this type of diseases, commonly known as "invisible diseases", generated an expenditure of 109.8 billion euros, which represents 9.1% of GDP. This is why research and technological development projects such as those to be carried out by Ionclinics are very important mechanisms not only for improving the health and quality of life of the population, but also for achieving better social benefits derived from the resources allocated for this purpose.